{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:14:09Z","timestamp":1794021249715,"version":"4.8.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.preghy.2024.101131","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T17:24:00Z","timestamp":1717781040000},"page":"101131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Aspirin resistance in pregnancy is associated with reduced interleukin-2 (IL-2) concentrations in maternal serum: Implications for aspirin prophylaxis for preeclampsia"],"prefix":"10.1016","volume":"37","author":[{"given":"Fernando","family":"Hernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie L.","family":"Goemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeva","family":"Kirakosyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Diaz","family":"Luevano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Canfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C.","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marni","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Woelkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Tarsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Gyamfi-Bannerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Fisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2024.101131_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136985","article-title":"The road to low-dose aspirin therapy for the prevention of preeclampsia began with the placenta","volume":"22","author":"Walsh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preghy.2024.101131_b0010","doi-asserted-by":"crossref","first-page":"S963","DOI":"10.1016\/j.ajog.2020.10.023","article-title":"An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array","volume":"226","author":"Yagel","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2024.101131_b0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM198908103210603","article-title":"The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane a2 to prostcyclin in relatively high risk pregnancies","volume":"321","author":"Schiff","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2024.101131_b0020","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2024.101131_b0025","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","article-title":"Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women","volume":"329","author":"Sibai","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2024.101131_b0030","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2024.101131_b0035","doi-asserted-by":"crossref","unstructured":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 343 (1994) 619\u2013629.","DOI":"10.1016\/S0140-6736(94)92633-6"},{"key":"10.1016\/j.preghy.2024.101131_b0040","doi-asserted-by":"crossref","unstructured":"Italian Study of Aspirin in Pregnancy. Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Lancet 341 (1993) 396\u2013400.","DOI":"10.1016\/0140-6736(93)92988-6"},{"key":"10.1016\/j.preghy.2024.101131_b0045","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","article-title":"Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai R\u00e9gional Aspirine M\u00e8re-Enfant study (Part 1)","volume":"110","author":"Subtil","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2024.101131_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(86)91891-X","article-title":"Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae","volume":"1","author":"Wallenburg","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2024.101131_b0055","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jama.2021.8551","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the US preventive services task force","volume":"326","author":"Henderson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.preghy.2024.101131_b0060","doi-asserted-by":"crossref","unstructured":"ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy. Obstet. Gynecol. 132 (2018) e44\u2013e52.","DOI":"10.1097\/AOG.0000000000002708"},{"key":"10.1016\/j.preghy.2024.101131_b0065","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(06)68040-9","article-title":"Aspirin resistance","volume":"367","author":"Hankey","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2024.101131_b0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.preghy.2019.11.008","article-title":"Resistance of aspirin during and after pregnancy: a longitudinal cohort study","volume":"19","author":"Bij de Weg","year":"2020","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2024.101131_b0075","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/eurheartj\/ehn562","volume":"30","author":"Kuliczkowski","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.preghy.2024.101131_b0080","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/1471-0528.13914","article-title":"Low dose aspirin and pregnancy: how important is aspirin resistance?","volume":"123","author":"Navaratnam","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2024.101131_b0085","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1701-2163(16)34346-8","article-title":"Low-dose ASA response using the PFA-100 in women with high-risk pregnancy","volume":"31","author":"Caron","year":"2009","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.preghy.2024.101131_b0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejogrb.2011.02.026","article-title":"Is testing for aspirin response worthwhile in high-risk pregnancy?","volume":"157","author":"Rey","year":"2011","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.preghy.2024.101131_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2021.103320","article-title":"Low Dose Aspirin in high-risk pregnancies: The volatile effect of acetylsalicylic acid on the inhibition of platelets uncovered by G. Born\u2019s light transmission aggregometry","volume":"145","author":"Stern","year":"2021","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.preghy.2024.101131_b0100","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/HYPERTENSIONAHA.119.14107","article-title":"Clinical influence of nonadherence with prophylactic aspirin in preventing preeclampsia in high-risk pregnancies","volume":"75","author":"Shanmugalingam","year":"2020","journal-title":"Hypertension"},{"issue":"630","key":"10.1016\/j.preghy.2024.101131_b0105","first-page":"e1","article-title":"Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia","volume":"200","author":"Sibai","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2024.101131_b0110","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0002-9378(98)70130-9","article-title":"Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units","volume":"179","author":"Hauth","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"512","key":"10.1016\/j.preghy.2024.101131_b0115","first-page":"e1","article-title":"Preeclampsia in high risk women is characterized by risk group-specific abnormalities in serum biomarkers","volume":"211","author":"Metz","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2024.101131_b0120","doi-asserted-by":"crossref","first-page":"e13263","DOI":"10.1371\/journal.pone.0013263","article-title":"Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies","volume":"5","author":"Powers","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.preghy.2024.101131_b0125","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc."},{"key":"10.1016\/j.preghy.2024.101131_b0130","series-title":"New S Language","author":"Becker","year":"1988"},{"key":"10.1016\/j.preghy.2024.101131_b0135","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v082.i13","article-title":"LmerTest package: tests in linear mixed effects models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.preghy.2024.101131_b0140","unstructured":"D.L. Rolnik, K.H. Nicolaides, L.C. Poon, Prevention of preeclampsia with aspirin. Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2024.101131_b0145","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/pd.4403","article-title":"Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation","volume":"34","author":"Bujold","year":"2014","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.preghy.2024.101131_b0150","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0037-1613805","article-title":"Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100","volume":"83","author":"Homoncik","year":"2000","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.preghy.2024.101131_b0155","article-title":"Aspirin resistance \u2013 clinically meaningful or a laboratory artefact?","volume":"3","author":"Blinc","year":"2005","journal-title":"European Society of Cardiology e-Journal of Cardiology Practice"},{"issue":"255","key":"10.1016\/j.preghy.2024.101131_b0160","first-page":"e1","article-title":"A pharmacokinetic assessment of optimal dosing, preparation, and chronotherapy of aspirin in pregnancy","volume":"221","author":"Shanmugalingam","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"385","key":"10.1016\/j.preghy.2024.101131_b0165","first-page":"e1","article-title":"Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin","volume":"220","author":"Finneran","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2024.101131_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2020.100184","article-title":"Low-dose aspirin for preeclampsia prevention: efficacy by ethnicity and race","volume":"2","author":"Tolcher","year":"2020","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"10.1016\/j.preghy.2024.101131_b0175","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211044723","article-title":"The pre- and postoperative prevalence and risk factors of ASA nonresponse in vascular surgery","volume":"27","author":"Kazimi","year":"2021","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.preghy.2024.101131_b0180","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-1-62703-435-7_20","article-title":"PharmGKB: the pharmacogenomics knowledge base","volume":"1015","author":"Thorn","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.preghy.2024.101131_b0185","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cpt.1830","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs","volume":"108","author":"Theken","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.preghy.2024.101131_b0190","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00228-013-1477-9","article-title":"Pharmacogenomics of acetylsalicylic acid and other nonsteroidal anti-inflammatory agents: clinical implications","volume":"69","author":"Yiannakopoulou","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.preghy.2024.101131_b0195","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/bcpt.13308","article-title":"Aspirin for the prevention and treatment of pre-eclampsia: a matter of COX-1 and\/or COX-2 inhibition?","volume":"127","author":"Mirabito Colafella","year":"2020","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.preghy.2024.101131_b0200","article-title":"Application of low dose aspirin in pre-eclampsia","volume":"10","author":"Ren","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.preghy.2024.101131_b0205","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1016\/j.ajpath.2016.08.010","article-title":"Low-dose acetylsalicylic acid treatment modulates the production of cytokines and improves trophoblast function in an in vitro model of early-onset preeclampsia","volume":"186","author":"Panagodage","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.preghy.2024.101131_b0210","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.preghy.2021.09.003","article-title":"Low-dose aspirin increases 15-epi-lipoxins A4 in pregnancies at high-risk for developing preeclampsia","volume":"26","author":"Gonzalez-Brown","year":"2021","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2024.101131_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254606","article-title":"Physiologically relevant aspirin concentrations trigger immunostimulatory cytokine production by human leukocytes","volume":"16","author":"Brox","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.preghy.2024.101131_b0220","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0162-3109(89)90045-3","article-title":"Aspirin and thymosin increase interleukin-2 and interferon-gamma production by human peripheral blood lymphocytes","volume":"17","author":"Hsia","year":"1989","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.preghy.2024.101131_b0225","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0897.1997.tb00281.x","article-title":"Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-\u03b1 levels before the clinical manifestations of preeclampsia","volume":"38","author":"Hamai","year":"1997","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.preghy.2024.101131_b0230","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.coi.2011.08.003","article-title":"IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation","volume":"23","author":"Liao","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.preghy.2024.101131_b0235","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-0897.2007.00491.x","article-title":"Maternal serum interleukin-10, interleukin-2 and interleukin-6 in pre-eclampsia and eclampsia","volume":"58","author":"Borekci","year":"2007","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.preghy.2024.101131_b0240","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.preghy.2011.09.005","article-title":"Comparison of maternal serum levels of interleukin-10, interleukin-12, and interleukin-2 in normal and preeclamptic pregnancies","volume":"2","author":"Celik","year":"2012","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2024.101131_b0245","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.277.5332.1669","article-title":"Regulation of human placental development by oxygen tension","volume":"277","author":"Genbacev","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.preghy.2024.101131_b0250","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x2020e9570","article-title":"Effects of aspirin, vitamin D3, and progesterone on pregnancy outcomes in an autoimmune recurrent spontaneous abortion model","volume":"54","author":"Chen","year":"2021","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.preghy.2024.101131_b0255","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-0378(03)00045-7","article-title":"Th1\/Th2 balance in preeclampsia","volume":"59","author":"Saito","year":"2003","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.preghy.2024.101131_b0260","doi-asserted-by":"crossref","DOI":"10.1186\/s12958-022-01003-3","article-title":"Diagnostic biomolecules and combination therapy for pre-eclampsia","volume":"20","author":"Qi","year":"2022","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.preghy.2024.101131_b0265","first-page":"73","article-title":"Interleukin-2 receptor serum concentrations in normal pregnancy and pre-eclampsia","volume":"43","author":"Romero-Adri\u00e1n","year":"2002","journal-title":"Invest. Clin."},{"key":"10.1016\/j.preghy.2024.101131_b0270","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2172-11-59","article-title":"Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array","volume":"11","author":"Szarka","year":"2010","journal-title":"BMC Immunol."},{"key":"10.1016\/j.preghy.2024.101131_b0275","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.cca.2011.06.042","article-title":"Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia","volume":"412","author":"Molvarec","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.preghy.2024.101131_b0280","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1600-0897.2010.00903.x","article-title":"Role of endothelin and inflammatory cytokines in pre-eclampsia - A pilot North Indian study","volume":"65","author":"Sharma","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.preghy.2024.101131_b0285","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4081\/reumatismo.2012.314","article-title":"Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus","volume":"64","author":"Iaccarino","year":"2012","journal-title":"Reumatismo"},{"key":"10.1016\/j.preghy.2024.101131_b0290","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/ar3782","article-title":"Effect of pregnancy on serum cytokines in SLE patients","volume":"14","author":"Doria","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.preghy.2024.101131_b0295","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.0405445101","article-title":"Aspirin triggers antiinflammatory 15-epi-lipoxin A 4 and inhibits thromboxane in a randomized human trial","volume":"101","author":"Chiang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778924001582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778924001582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T10:59:40Z","timestamp":1732186780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778924001582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":59,"alternative-id":["S2210778924001582"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2024.101131","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin resistance in pregnancy is associated with reduced interleukin-2 (IL-2) concentrations in maternal serum: Implications for aspirin prophylaxis for preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2024.101131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy.","name":"copyright","label":"Copyright"}],"article-number":"101131"}}